Connect with us

Technology

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Published

on

Marpai’s turnaround momentum is building

TAMPA, Fla., May 14, 2025 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on May 15, 2025.

Marpai CEO Damien Lamendola commented, “Our consistent double-digit success in cutting operating expenses and improving our bottom line signals what we believe is a critical inflection point for the Company. Looking ahead to the second quarter, we are focused on completing several key initiatives, including the launch of our Healthcare Management tool with Empara, LLC (“Empara”), exciting advancements with MarpaiRx, and the onboarding of our new Chief Operating Officer, Dallas Scrip. Our unwavering goal is to achieve profitability and positive cash flow by the end of 2025.”

Q1 2025 Financial Highlights:

Net revenues were approximately $5.4 million for the three months ended March 31, 2025, down $2.0 million, or 27% lower year over year, compared to the three months ended March 31, 2024.Operating expenses were $7.7 million for the three months ended March 31, 2025, down $3.8 million, or 33% lower year over year, compared to the three months ended March 31, 2024.Operating loss was $2.3 million for the three months ended March 31, 2025, lower by $1.8 million, or 45% lower year over year, compared to the three months ended March 31, 2024.Net loss was $3.1 million for the three months ended March 31, 2025, lower by $1.3 million, or 29% lower year over year, compared to the three months ended March 31, 2024.Basic and diluted earnings per share were ($0.21) for the three months ended March 31, 2025, an improvement of $0.25 per share year over year, compared to the three months ended March 31, 2024.The Company had $0.7 million in unrestricted cash on hand at the end of three months ended March 31, 2025, down $0.1 million from the three months ended March 31, 2024.

Webcast and Conference Call Information

Marpai expects to host a conference call and webcast on Thursday, May 15, 2025, at 8:30 a.m. ET to review the Company’s operational and financial highlights for its first quarter ended March 31, 2025.

Investors interested in listening to the conference call may do so by dialing (800)-836-8184 for domestic callers or +1-646-357-8785 for international callers, or via webcast: https://app.webinar.net/e6RGaxOgz3n

About Marpai, Inc.

Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guidance,” “may,” “can,” “could”, “will”, “potential”, “should,” “goal” and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses that it continues to make strong progress with its turnaround efforts, that improvements in its operating expenses and bottom line signals a critical inflection point for the Company, quarter, that it expects to complete several key initiatives, including the launch of its Healthcare Management tool with Empara and advancements with MarpaiRx, and that its goal remains profitability and positive cash flow by the end of 2025. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai’s current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai’s current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai’s filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov.

 

MARPAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET

(in thousands, except share and per share data)

(Unaudited)

March 31, 2025

December 31, 2024

ASSETS:

Current assets:

Cash and cash equivalents

$                         729

$                         764

Restricted cash

10,780

8,468

Accounts receivable, net of allowance for credit losses of $1 and $1 as of March 31,

2025 and Dec 31, 2024

368

837

Unbilled receivables

374

569

Due from buyer for sale of business unit

—

500

Prepaid expenses and other current assets

615

759

Total current assets

12,866

11,897

Capitalized software, net

334

441

Operating lease right-of-use assets

281

296

Security deposits 

229

229

Other long-term asset

8

15

Total assets

$                    13,718

$                    12,878

LIABILITIES AND STOCKHOLDERS’  DEFICIT

Current liabilities:

Accounts payable

$                      2,736

$                      3,109

Accrued expenses

1,906

2,585

Accrued fiduciary obligations

8,227

6,308

Deferred revenue

806

625

Current portion of operating lease liabilities

248

244

Current portion of convertible debentures, net

3,037

3,106

Other short-term liabilities

2,834

3,005

Total current liabilities

19,794

18,982

Other long-term liabilities

15,329

14,891

Convertible debentures, net of current portion

8,069

5,921

Operating lease liabilities, net of current portion

730

793

Total liabilities

43,922

40,587

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS’ DEFICIT

Common stock, $0.0001 par value, 227,791,050 shares authorized; 14,896,686

shares and 14,237,176 shares issued and outstanding at March 31, 2025 and

December 31, 2024, respectively

1

1

Additional paid-in capital

71,698

71,124

Accumulated deficit

(101,903)

(98,834)

Total stockholders’ deficit

(30,204)

(27,709)

Total liabilities and stockholders’ deficit

$                    13,718

$                    12,878

 

MARPAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

(Unaudited)

Three Months Ended 

March 31, 2025

March 31, 2024

Revenue

$                      5,418

$                      7,385

Costs and expenses

Cost of revenue (exclusive of depreciation and amortization shown separately below)

3,484

4,871

General and administrative

2,283

3,421

Information technology

1,390

1,124

Sales and marketing

245

602

Research and development

7

7

Depreciation and amortization

107

951

Facilities

152

474

    Total costs and expenses

7,668

11,450

Operating loss

(2,250)

(4,065)

Other income (expenses)

Other income

—

120

Interest expense, net

(819)

(398)

Foreign exchange loss

—

(3)

Loss before provision for income taxes

(3,069)

(4,346)

Income tax expense

—

—

Net loss

$                    (3,069)

$                    (4,346)

Net loss per share, basic & fully diluted

$                      (0.21)

$                      (0.46)

Weighted average common shares outstanding, basic and diluted

14,770,867

9,405,775

 

MARPAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

Three Months Ended 

March 31, 2025

March 31, 2024

Cash flows from operating activities:

Net loss

$                    (3,069)

$                    (4,346)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

107

951

Share-based compensation

574

561

Amortization of right-of-use asset

15

62

Non-cash interest expense

463

423

Amortization of debt premium and debt issuance costs

(9)

—

Changes in operating assets and liabilities:

Accounts receivable and unbilled receivables

664

800

Prepaid expense and other assets

151

(99)

Accounts payable

(373)

(825)

Accrued expenses

(679)

215

Accrued fiduciary obligations

1,919

(2,063)

Operating lease liabilities

(59)

(126)

Other liabilities

181

862

    Net cash used in operating activities

(115)

(3,585)

Cash flows from investing activities:

Proceeds from sale of business unit

500

—

Net cash provided by investing activities

500

—

Cash flows from financing activities:

Proceeds from sale of future cash receipts on accounts receivable

—

1,509

Proceeds from issuance of convertible debentures

3,000

—

Payments of debt issuance costs

(162)

—

Payments to buyer of receivables

—

(57)

Payments on convertible debentures

(750)

—

Payments to seller for acquisition

(196)

(474)

Proceeds from issuance of common stock in a private offering, net

—

2,727

Net cash provided by financing activities

1,892

3,705

Net increase in cash, cash equivalents and restricted cash

2,277

120

Cash, cash equivalents and restricted cash at beginning of period

9,232

13,492

Cash, cash equivalents and restricted cash at end of period

$                    11,509

$                    13,612

Reconciliation of cash, cash equivalents, and restricted cash reported in
   the condensed consolidated balance sheet

Cash and cash equivalents

$                         729

$                         851

Restricted cash

10,780

12,761

Total cash, cash equivalents and restricted cash shown in the condensed
   consolidated statement of cash flows

$                    11,509

$                    13,612

Supplemental disclosure of cash flow information

Cash paid for interest

$                         403

$                           —

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-reports-first-quarter-2025-financial-results-302455515.html

SOURCE Marpai

Continue Reading

Technology

Mission Critical Partners Announces Launch of its Justice Integration Hub in Support of the City of New Orleans

Published

on

By

The $30 million ARPA-funded initiative connects public-safety and justice agencies, accelerates case processing and improves service to the community.

NEW ORLEANS, Oct. 27, 2026 /PRNewswire-PRWeb/ — Mission Critical Partners today announced the launch of its Justice Integration Hub in support of the city of New Orleans’ Justice Technology Modernization Program (JTMP). JTMP is a multiyear initiative that replaced several decades-old systems with a unified, cloud-based platform designed to improve public safety and access to justice by streamlining operations and strengthening transparency across the city and Orleans Parish criminal-justice ecosystem.

“The Justice Integration Hub is not just a technology milestone; it’s a fundamental shift in how justice is delivered,” said Darrin Reilly, president and CEO, Mission Critical Partners.

The Justice Integration Hub facilitates the seamless flow of information throughout the Parish’s complex criminal-justice ecosystem. Funded through a $30 million allocation from the American Rescue Plan Act (ARPA), JTMP represents one of the most comprehensive justice technology overhauls in the country, modernizing and transforming more than 40 years of legacy infrastructure. The program integrates the area’s entire criminal justice ecosystem — including the New Orleans Police Department, Orleans Parish Sheriff’s Office and Justice Center, District Attorney, Public Defender, Criminal District Court, and Clerk of Court — into a single, connected environment.

“The integration hub fundamentally changes how our justice agencies work together,” said Nathaniel Weaver, JTMP director. “Instead of information stopping at the boundaries between agencies, it can move securely in real time, allowing people to spend less time reentering data and more time making the decisions that move cases forward.”

From Fragmentation to Real-Time Coordination

For years, criminal-justice agencies in New Orleans and Orleans Parish operated on outdated, siloed systems that limited collaboration, slowed case processing, and created cross-department inefficiencies.

The Justice Enterprise Hub is built on Microsoft Azure and leverages a standardized enterprise data model aligned with national data-sharing models. A secure integration hub enables real-time data sharing across agencies, ensuring that critical information is accessible when and where it is needed.

Immediate Impact Across the Community

The Justice Enterprise Hub already is helping to deliver measurable improvements:

Patrol officers now have additional hours each week to spend in New Orleans communities and respond to emergencies due to more efficient digital arrest-processing workflows.Data sharing from the jail to the court facilitates automated creation of cases and scheduling of court appearances, saving approximately 6,000 hours of time clerks would spend on data entry.Faster information sharing between agencies is helping reduce hearing delays, streamline inmate transport coordination, and improve overall justice system efficiency. This significantly reduces incarceration costs and generates measurable operational savings.

A Foundation for the Future of Justice

With the core platform now fully operational, New Orleans and Orleans Parish are positioned to build on this foundation with advanced capabilities, including AI-assisted case processing, digital evidence management, and expanded state-level data integration.

“The Justice Integration Hub is not just a technology milestone; it’s a fundamental shift in how justice is delivered,” said Darrin Reilly, MCP’s president and CEO. “New Orleans and Orleans Parish now have a nation-leading, scalable, and future-ready system that enables agencies to work together more effectively and collaboratively to better serve the public. We look forward to bringing this solution to more communities across the nation.”

The system was implemented in four phases, following a competitive nationwide process that selected Mission Critical Partners and Major Services, a New Orleans-based IT consulting firm, to oversee JTMP’s development, implementation, and coordinated go-live activities across all participating agencies. Those four phases went live in succession, between November 2025 and April 2026.

About Mission Critical Partners (MCP)

Mission Critical Partners (MCP) is a leading provider of data integration, consulting, network, and cybersecurity solutions specializing in transforming mission-critical communications networks into integrated ecosystems that improve outcomes in the public-safety, justice, healthcare, transportation, and utility markets. Our comprehensive experience and vendor-agnostic approach help us develop modernized solutions that maximize value, improve efficiency, and mitigate risk. Additional information and career opportunities are available at MissionCriticalPartners.com.

Media Contact

Morgan Sava, Mission Critical Partners, 1 608-658-8858, rscarpino@pipitone.com, https://www.missioncriticalpartners.com/

View original content:https://www.prweb.com/releases/mission-critical-partners-announces-launch-of-its-justice-integration-hub-in-support-of-the-city-of-new-orleans-302920918.html

SOURCE Mission Critical Partners

Continue Reading

Technology

MadeAi Launches Dossier Expert, Bringing Agentic AI to Formulary and Value Dossier Development

Published

on

By

New AI-powered solution transforms dossier creation and maintenance with source-level traceability, cross-functional collaboration, and up to 70% faster authoring and updates

CAMBRIDGE, Mass., Oct. 27, 2026 /PRNewswire-PRWeb/ — MadeAi™, a leader in AI-enabled evidence synthesis and life sciences solutions, today announced the launch of MadeAi Dossier Expert, a new AI-powered solution designed to transform how pharmaceutical and life sciences organizations create, review, and maintain formulary and value dossiers.

Traditionally, developing AMCP dossiers, global value dossiers, and health technology assessment (HTA) submissions requires months of coordination across HEOR, Clinical, Market Access, and Medical Writing teams. Evidence is dispersed across multiple sources, citations require extensive manual verification, and updates often trigger lengthy rounds of rewriting and review.

Dossier Expert replaces this fragmented process with a living, evidence-linked document that evolves as the underlying science changes.

Built to address one of the most time-consuming challenges facing Market Access and HEOR teams, Dossier Expert brings evidence management, AI-assisted authoring, citation verification, and cross-functional collaboration into a single, continuously updated environment.

From Static Documents to Living Evidence

Unlike traditional dossier authoring approaches that focus primarily on accelerating initial drafts, Dossier Expert is designed to streamline the entire dossier lifecycle—from first creation through ongoing evidence updates.

Key capabilities include:

AI-Powered Dossier Generation: Create structured AMCP, HTA, and value dossiers using customizable templates and AI-generated, evidence-grounded content.One-Click Citation Verification: Trace every AI-generated claim directly to its source document, with the supporting passage highlighted for immediate verification.Intelligent Evidence Updates: Automatically identify sections affected by changes in underlying evidence and selectively regenerate outdated content without overwriting human edits.Integrated Evidence Hub: Organize and connect indexed source materials directly to relevant dossier sections.Integrated MadeAi-LR: Access AI-enabled literature review directly for in-platform literature review support.Seamless Collaboration: Enable HEOR, Clinical, Market Access, and Medical Writing teams to work within one document, with built-in commenting, assignments, approvals, and version control.Flexible, Submission-Ready Outputs: Export approved dossiers to Word or PDF.

Accelerating Market Access Without Compromising Scientific Rigor

Dossier Expert is designed to deliver up to 70% faster dossier authoring and updates, while reducing the manual effort associated with evidence verification, document management, and recurring revisions.

“Creating a dossier is only part of the challenge. Keeping it scientifically current, fully traceable, and aligned across multiple stakeholders is where organizations lose enormous amounts of time,” said Gaugarin Oliver, Founder and CEO of MadeAi. “With Dossier Expert, we’re moving beyond AI-generated first drafts to a fundamentally different model: a living dossier that connects every claim to its evidence, identifies what needs updating, and enables experts to focus on scientific judgment rather than document administration.”

By combining AI-powered efficiency with human oversight and transparent source verification, Dossier Expert helps life sciences organizations accelerate evidence communication while maintaining the rigor required for payer and HTA engagement.

Learn more about Dossier Expert at www.madeai.com.

About MadeAi

MadeAi™ is an award-winning AI-native evidence synthesis and life sciences solutions platform designed to help pharmaceutical, biotechnology, and medical device organizations accelerate evidence generation and scientific communication. Combining advanced agentic AI capabilities with human expertise, MadeAi supports workflows across HEOR, Market Access, Medical Affairs, and RWE, delivering greater efficiency, transparency, and scientific rigor.

Media Contact

Meghan Oates-Zalesky, MadeAi, 1 617 435 2470, meghan.oates@madeai.com, www.madeai.com

View original content to download multimedia:https://www.prweb.com/releases/madeai-launches-dossier-expert-bringing-agentic-ai-to-formulary-and-value-dossier-development-302920940.html

SOURCE MadeAi

Continue Reading

Technology

Peloton Launches Peloton Broker to Streamline Early-Stage Land Acquisition for Energy Projects

Published

on

By

New tract-based pre-leasing tool joins the
Land Data Management solution in the Peloton Platform

CALGARY, AB, Oct. 27, 2026 /PRNewswire/ — Peloton, a provider of energy data management software, today announced the launch of Peloton Broker, a tract-based pre-leasing management tool built for energy projects. Peloton Broker gives brokers, consultants, land departments, and legal teams one place to handle ownership discovery, negotiation tracking, and title curative work, so they can move from prospect to signed lease without re-entering data or juggling separate systems.

Peloton Broker is part of Peloton’s Land Data Management solution in the Peloton Platform, alongside LandView, LandView Map, and Peloton Dashboards. It extends Peloton’s trusted foundation to the earliest stage of land acquisition, with pre-leasing work carrying straight into agreement-based lease management in LandView.

“The pre-leasing stage has always been where land data is most scattered, with ownership research in one place, negotiation notes in another, and title issues surfacing late,” said James Hatcher, Product Manager – Land Data Management at Peloton. “Peloton Broker brings that work into the Peloton Platform from day one, so land teams start every lease with a complete picture and the rest of the organization gets land data it can trust.”

Built for the start of the lease lifecycle

Peloton Broker helps land teams at oil and gas operators and renewable energy developers:

Track ownership at the tract level, covering both surface and mineral rightsManage negotiations in integrated workflows that record every offer, contact, and status changeCatch title concerns early with title curative support, before they hold up executionWork from the map with GIS-driven prospect management connected to LandView MapKeep audit-ready records with full traceability from first contact to executed lease

Connected across the Peloton Platform

The Peloton Platform is a SaaS solution hosted by Microsoft Azure that brings well, production, and land data together in one environment. With Peloton Broker on the platform, customers get:

A single source of truth. Land, operations, and finance teams work from the same accurate, up-to-date information, with master data such as business associates, wells, and units shared across products.Linked lifecycles. Land data ties into well and production data in WellView and ProdView, and integrates with third-party ERP and financial systems.Enterprise-grade security, backed by Peloton’s SOC 1 and SOC 2 Type 2 certifications.

Peloton Broker is available now. To learn more, visit peloton.com/products/land-data-management/broker.

About Peloton

Headquartered in Calgary, Alberta, and founded in 1991, Peloton created the energy industry’s original data management solution, and it remains the standard today. With more than three decades of industry expertise and over 700 clients globally, Peloton offers software across the well, production, and land lifecycles. The Peloton Platform brings all three together in one integrated SaaS environment, hosted by Microsoft Azure.

View original content to download multimedia:https://www.prnewswire.com/news-releases/peloton-launches-peloton-broker-to-streamline-early-stage-land-acquisition-for-energy-projects-302921122.html

SOURCE Peloton Computer Enterprises Ltd.

Continue Reading

Trending